Luminate Medical Joins Y Combinator S21 Batch

Luminate Medical has received the backing of world-renowned technology accelerator Y Combinator to continue developing its novel solution to prevent chemotherapy induced hair loss. The company now joins an impressive list of alumni which includes some of the world's largest companies such as Airbnb, Stripe, and Dropbox.

Based in Galway, Ireland, Luminate Medical is a medical device company which focuses on the development of devices which can eliminate the side effects of drug treatments. Founded in 2019, the company is currently focused on developing its Lily device, a novel treatment for chemotherapy induced alopecia.

As part of the Y Combinator program, the company will undergo an intense acceleration program over the next 12 weeks as it prepares to raise seed funding in Autumn 2021.

"We are incredibly proud that Y Combinator has embraced our mission of ending chemotherapy induced hair loss," commented Aaron Hannon, CEO of Luminate Medical. "This is another endorsement of the amazing team and technology we have built. As part of the YC S21 batch, we will continue to focus on how we can best serve cancer patients in undergoing treatment with dignity."